Compounds > prednisone
Page last updated: 2024-08-17

prednisone and olsalazine

prednisone has been researched along with olsalazine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Benin, A; Lennard, L; Lewis, LD; Nierenberg, DW; Otterness, DM; Szumlanski, CL; Weinshilboum, RM1
Cosnes, J; Elefant, E; Gendre, JP; Marteau, P; Modigliani, R; Rambaud, JC; Tennenbaum, R1

Reviews

1 review(s) available for prednisone and olsalazine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for prednisone and olsalazine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction.
    Clinical pharmacology and therapeutics, 1997, Volume: 62, Issue:4

    Topics: Adolescent; Aminosalicylic Acids; Anti-Inflammatory Agents; Bone Marrow; Crohn Disease; Drug Interactions; Humans; Immunosuppressive Agents; Mercaptopurine; Prednisone

1997
[Pregnancy outcome in inflammatory bowel diseases].
    Gastroenterologie clinique et biologique, 1999, Volume: 23, Issue:5

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Mesalamine; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prognosis; Surveys and Questionnaires

1999